Expression of fibronectin splicing variants in organ transplantation

A differential pattern between rat cardiac allografts and isografts

Ana J. Coito, Lawrence F. Brown, John H. Peters, Jerzy W. Kupiec-Weglinski, Livingston Van De Water

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Allograft rejection is associated with infiltration of inflammatory cells and deposition of extracellular matrix proteins. The extent to which diversity in the extracellular matrix regulates inflammatory cell function in transplants remains unclear. One group of extracellular matrix proteins, termed fibronectins (FNs), exhibits inherent diversity as a consequence of alternative splicing in three segments: EIIIA, EIIIB, or V. Although the EIIIA segment has documented functions in mesenchymal cell differentiation, neither this segment nor the EIIIB segment have been tested for effects specific to leukocyte functions. By contrast, the V region can include the CS-1 segment to which leukocytes may adhere through α4β1 integrins. In this study, we demonstrate that EIIIA+, EIIIB+, and V+ FN variants are synthesized, primarily by macrophages in distinct temporal and spatial patterns in two rat cardiac transplant models: either with antigenic challenge, allografts, or without challenge, isografts. The ratio of EIIIA inclusion into FN increases by day 1 in allografts and isografts and remains high until allografts are rejected (~7 days) but falls to normal levels in tolerated isografts (day 6). EIIIB+ FN ratios in allografts peak later than do EIIIA+ FNs (day 4). EIIIB+ FN ratios remain relatively low in isografts. Interesting, EIIIA+ and EIIIB+ FNs are deposited prominently in the myocardium of rejecting allografts in close association with infiltrating leukocytes, and FN expression and deposition are prominent at sites of infarction. By contrast, these FNs are largely restricted to the epicardium and to a lesser degree in the immediately adjacent myocardium in isografts. CS-1+ FNs increase in allografts and isografts at 3 hours after transplantation but are particularly prominent in allografts 1 to 3 days before rejection. Our data suggest that FN splicing variants have a differential role in the effector functions of leukocytes in allografts and isografts and provide a foundation for testing their function on leukocytes and a rationale for FN-based therapeutics to modulate allograft rejection in transplant recipients.

Original languageEnglish (US)
Pages (from-to)1757-1772
Number of pages16
JournalAmerican Journal of Pathology
Volume150
Issue number5
StatePublished - 1997
Externally publishedYes

Fingerprint

Isografts
Organ Transplantation
Fibronectins
Allografts
Leukocytes
Extracellular Matrix Proteins
Myocardium
Transplants
Pericardium
Alternative Splicing
Integrins
Infarction
Extracellular Matrix
Cell Differentiation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Coito, A. J., Brown, L. F., Peters, J. H., Kupiec-Weglinski, J. W., & Van De Water, L. (1997). Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts. American Journal of Pathology, 150(5), 1757-1772.

Expression of fibronectin splicing variants in organ transplantation : A differential pattern between rat cardiac allografts and isografts. / Coito, Ana J.; Brown, Lawrence F.; Peters, John H.; Kupiec-Weglinski, Jerzy W.; Van De Water, Livingston.

In: American Journal of Pathology, Vol. 150, No. 5, 1997, p. 1757-1772.

Research output: Contribution to journalArticle

Coito, AJ, Brown, LF, Peters, JH, Kupiec-Weglinski, JW & Van De Water, L 1997, 'Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts', American Journal of Pathology, vol. 150, no. 5, pp. 1757-1772.
Coito, Ana J. ; Brown, Lawrence F. ; Peters, John H. ; Kupiec-Weglinski, Jerzy W. ; Van De Water, Livingston. / Expression of fibronectin splicing variants in organ transplantation : A differential pattern between rat cardiac allografts and isografts. In: American Journal of Pathology. 1997 ; Vol. 150, No. 5. pp. 1757-1772.
@article{c88d5a2d05294d41b18262dfc23607c1,
title = "Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts",
abstract = "Allograft rejection is associated with infiltration of inflammatory cells and deposition of extracellular matrix proteins. The extent to which diversity in the extracellular matrix regulates inflammatory cell function in transplants remains unclear. One group of extracellular matrix proteins, termed fibronectins (FNs), exhibits inherent diversity as a consequence of alternative splicing in three segments: EIIIA, EIIIB, or V. Although the EIIIA segment has documented functions in mesenchymal cell differentiation, neither this segment nor the EIIIB segment have been tested for effects specific to leukocyte functions. By contrast, the V region can include the CS-1 segment to which leukocytes may adhere through α4β1 integrins. In this study, we demonstrate that EIIIA+, EIIIB+, and V+ FN variants are synthesized, primarily by macrophages in distinct temporal and spatial patterns in two rat cardiac transplant models: either with antigenic challenge, allografts, or without challenge, isografts. The ratio of EIIIA inclusion into FN increases by day 1 in allografts and isografts and remains high until allografts are rejected (~7 days) but falls to normal levels in tolerated isografts (day 6). EIIIB+ FN ratios in allografts peak later than do EIIIA+ FNs (day 4). EIIIB+ FN ratios remain relatively low in isografts. Interesting, EIIIA+ and EIIIB+ FNs are deposited prominently in the myocardium of rejecting allografts in close association with infiltrating leukocytes, and FN expression and deposition are prominent at sites of infarction. By contrast, these FNs are largely restricted to the epicardium and to a lesser degree in the immediately adjacent myocardium in isografts. CS-1+ FNs increase in allografts and isografts at 3 hours after transplantation but are particularly prominent in allografts 1 to 3 days before rejection. Our data suggest that FN splicing variants have a differential role in the effector functions of leukocytes in allografts and isografts and provide a foundation for testing their function on leukocytes and a rationale for FN-based therapeutics to modulate allograft rejection in transplant recipients.",
author = "Coito, {Ana J.} and Brown, {Lawrence F.} and Peters, {John H.} and Kupiec-Weglinski, {Jerzy W.} and {Van De Water}, Livingston",
year = "1997",
language = "English (US)",
volume = "150",
pages = "1757--1772",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Expression of fibronectin splicing variants in organ transplantation

T2 - A differential pattern between rat cardiac allografts and isografts

AU - Coito, Ana J.

AU - Brown, Lawrence F.

AU - Peters, John H.

AU - Kupiec-Weglinski, Jerzy W.

AU - Van De Water, Livingston

PY - 1997

Y1 - 1997

N2 - Allograft rejection is associated with infiltration of inflammatory cells and deposition of extracellular matrix proteins. The extent to which diversity in the extracellular matrix regulates inflammatory cell function in transplants remains unclear. One group of extracellular matrix proteins, termed fibronectins (FNs), exhibits inherent diversity as a consequence of alternative splicing in three segments: EIIIA, EIIIB, or V. Although the EIIIA segment has documented functions in mesenchymal cell differentiation, neither this segment nor the EIIIB segment have been tested for effects specific to leukocyte functions. By contrast, the V region can include the CS-1 segment to which leukocytes may adhere through α4β1 integrins. In this study, we demonstrate that EIIIA+, EIIIB+, and V+ FN variants are synthesized, primarily by macrophages in distinct temporal and spatial patterns in two rat cardiac transplant models: either with antigenic challenge, allografts, or without challenge, isografts. The ratio of EIIIA inclusion into FN increases by day 1 in allografts and isografts and remains high until allografts are rejected (~7 days) but falls to normal levels in tolerated isografts (day 6). EIIIB+ FN ratios in allografts peak later than do EIIIA+ FNs (day 4). EIIIB+ FN ratios remain relatively low in isografts. Interesting, EIIIA+ and EIIIB+ FNs are deposited prominently in the myocardium of rejecting allografts in close association with infiltrating leukocytes, and FN expression and deposition are prominent at sites of infarction. By contrast, these FNs are largely restricted to the epicardium and to a lesser degree in the immediately adjacent myocardium in isografts. CS-1+ FNs increase in allografts and isografts at 3 hours after transplantation but are particularly prominent in allografts 1 to 3 days before rejection. Our data suggest that FN splicing variants have a differential role in the effector functions of leukocytes in allografts and isografts and provide a foundation for testing their function on leukocytes and a rationale for FN-based therapeutics to modulate allograft rejection in transplant recipients.

AB - Allograft rejection is associated with infiltration of inflammatory cells and deposition of extracellular matrix proteins. The extent to which diversity in the extracellular matrix regulates inflammatory cell function in transplants remains unclear. One group of extracellular matrix proteins, termed fibronectins (FNs), exhibits inherent diversity as a consequence of alternative splicing in three segments: EIIIA, EIIIB, or V. Although the EIIIA segment has documented functions in mesenchymal cell differentiation, neither this segment nor the EIIIB segment have been tested for effects specific to leukocyte functions. By contrast, the V region can include the CS-1 segment to which leukocytes may adhere through α4β1 integrins. In this study, we demonstrate that EIIIA+, EIIIB+, and V+ FN variants are synthesized, primarily by macrophages in distinct temporal and spatial patterns in two rat cardiac transplant models: either with antigenic challenge, allografts, or without challenge, isografts. The ratio of EIIIA inclusion into FN increases by day 1 in allografts and isografts and remains high until allografts are rejected (~7 days) but falls to normal levels in tolerated isografts (day 6). EIIIB+ FN ratios in allografts peak later than do EIIIA+ FNs (day 4). EIIIB+ FN ratios remain relatively low in isografts. Interesting, EIIIA+ and EIIIB+ FNs are deposited prominently in the myocardium of rejecting allografts in close association with infiltrating leukocytes, and FN expression and deposition are prominent at sites of infarction. By contrast, these FNs are largely restricted to the epicardium and to a lesser degree in the immediately adjacent myocardium in isografts. CS-1+ FNs increase in allografts and isografts at 3 hours after transplantation but are particularly prominent in allografts 1 to 3 days before rejection. Our data suggest that FN splicing variants have a differential role in the effector functions of leukocytes in allografts and isografts and provide a foundation for testing their function on leukocytes and a rationale for FN-based therapeutics to modulate allograft rejection in transplant recipients.

UR - http://www.scopus.com/inward/record.url?scp=0030988946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030988946&partnerID=8YFLogxK

M3 - Article

VL - 150

SP - 1757

EP - 1772

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -